Loading...

Categories

9 Philippines Device Drug Combination Reports

Continuous Glucose Monitoring in Philippines Market

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Medtronic, Insulet Corporation, Novo Nordisk A/S, Sanofi, F. Hoffmann-La Roche Ltd

Philippines Oral Anti-Diabetic Drug Market

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Astrazeneca, Astellas, Janssen, Eli Lilly, Sanofi

Philippines Diabetes Drugs and Devices Market

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Medtronics, Roche, NovoNordisk, Sanofi, Omnipod

Asia-Pacific Insulin Pens Industry

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Biocon, Wockhardt, Novo Nordisk A/S, Eli Lilly and Company, Sanofi Aventis

Diabetes Care Devices Industry

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Novo Nordisk A/S, Medtronic, Dexcom Inc., Abbott Diabetes Care, Roche Diabetes Care

Insulin Delivery Devices Market

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Medtronic, Sanofi, Ypsomed, Eli Lilly and Company

Insulin Pens Market

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Novo Nordisk, Sanofi, Eli Lilly, Biocon, Julphar

Human Insulin Market

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Novo Nordisk, Sanofi, El lilly, Medtronics, Roche

Type 2 Diabetes Drugs And Devices Market

Country Covered: Philippines

Study Period: 2018-2029

Major Players: Abbott, Medtronic, Lilly, Novo Nordisk, Roche